{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:04:12Z","timestamp":1784077452873,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gazi University Scientific Research Projects Unit"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04944-w","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:44:06Z","timestamp":1779407046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma metabolomic and lipidomic profiling reveals distinct molecular signatures and time-dependent remodeling in ulcerative colitis"],"prefix":"10.1186","volume":"26","author":[{"given":"G\u00fclden","family":"Bilican","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurulamin M.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan L.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Petrousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Kirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevilay Erdo\u011fan","family":"Kablan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emirhan","family":"Nemutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011fda\u015f","family":"Kalkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Cindoruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Kekilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarkan","family":"Karakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"8067","key":"4944_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","volume":"642","author":"L Hracs","year":"2025","unstructured":"Hracs L, Windsor JW, Gorospe J, et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025;642(8067):458\u201366. https:\/\/doi.org\/10.1038\/s41586-025-08940-0.","journal-title":"Nature"},{"key":"4944_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, et al. Ulcerative colitis. Lancet (London England) vol. 2023;402:571\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2.","journal-title":"Lancet (London England) vol"},{"issue":"1","key":"4944_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.dld.2022.08.039","volume":"55","author":"N Dai","year":"2023","unstructured":"Dai N, Haidar O, Askari A, Segal JP. Colectomy rates in ulcerative colitis: A systematic review and meta-analysis. Dig Liver Dis. 2023;55(1):13\u201320. https:\/\/doi.org\/10.1016\/j.dld.2022.08.039.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"4944_CR4","doi-asserted-by":"publisher","first-page":"2310894","DOI":"10.1080\/19490976.2024.2310894","volume":"16","author":"B Han","year":"2024","unstructured":"Han B, Tang D, Lv X, et al. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-\u03b14\u03b27-integrin in Crohn\u2019s disease. Gut Microbes. 2024;16(1):2310894. https:\/\/doi.org\/10.1080\/19490976.2024.2310894.","journal-title":"Gut Microbes"},{"issue":"1","key":"4944_CR5","doi-asserted-by":"publisher","first-page":"2450207","DOI":"10.1080\/19490976.2025.2450207","volume":"17","author":"J O\u2019Sullivan","year":"2025","unstructured":"O\u2019Sullivan J, Patel S, Leventhal GE, et al. Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease. Gut Microbes. 2025;17(1):2450207. https:\/\/doi.org\/10.1080\/19490976.2025.2450207.","journal-title":"Gut Microbes"},{"issue":"6","key":"4944_CR6","doi-asserted-by":"publisher","first-page":"jjaf082","DOI":"10.1093\/ecco-jcc\/jjaf082","volume":"19","author":"AR Bourgonje","year":"2025","unstructured":"Bourgonje AR, Ibing S, Livanos AE, et al. Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease. J Crohns Colitis. 2025;19(6):jjaf082. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf082.","journal-title":"J Crohns Colitis"},{"key":"4944_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mrc.5350","volume":"61","author":"MJ Jeppesen","year":"2023","unstructured":"Jeppesen MJ, Powers R. Multiplatform untargeted metabolomics. Magn Reson chemistry: MRC vol. 2023;61:628\u201353. https:\/\/doi.org\/10.1002\/mrc.5350.","journal-title":"Magn Reson chemistry: MRC vol"},{"issue":"6","key":"4944_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s10620-018-5025-4","volume":"63","author":"S Nishiumi","year":"2018","unstructured":"Nishiumi S, Izumi Y, Yoshida M. Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice. Dig Dis Sci. 2018;63(6):1485\u201396. https:\/\/doi.org\/10.1007\/s10620-018-5025-4.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"4944_CR9","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/ibd\/izad298","volume":"30","author":"HC Tews","year":"2024","unstructured":"Tews HC, et al. Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn\u2019s Disease and Ulcerative Colitis Compared With Healthy Control Individuals. Inflamm bowel Dis vol. 2024;30(12):2405\u201317. https:\/\/doi.org\/10.1093\/ibd\/izad298.","journal-title":"Inflamm bowel Dis vol"},{"issue":"2","key":"4944_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izad154","volume":"30","author":"L Aldars-Garc\u00eda","year":"2024","unstructured":"Aldars-Garc\u00eda L, et al. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Na\u00efve Inflammatory Bowel Disease Patients. Inflamm bowel Dis vol. 2024;30(2):167\u201382. https:\/\/doi.org\/10.1093\/ibd\/izad154.","journal-title":"Inflamm bowel Dis vol"},{"key":"4944_CR11","doi-asserted-by":"publisher","unstructured":"Liu M, et al. Mar. Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways. Ther Adv Gastroenterol. 2024;17:17562848241239580. https:\/\/doi.org\/10.1177\/17562848241239580.","DOI":"10.1177\/17562848241239580"},{"key":"4944_CR12","doi-asserted-by":"publisher","first-page":"116652","DOI":"10.1016\/j.jpba.2024.116652","volume":"255","author":"NT Tien","year":"2025","unstructured":"Tien NT. An exploratory multi-omics study reveals distinct molecular signatures of ulcerative colitis and Crohn\u2019s disease and their correlation with disease activity. J Pharm Biomed Anal. 2025;255:116652. https:\/\/doi.org\/10.1016\/j.jpba.2024.116652.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"4944_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5152\/eurjrheum.2023.23062","volume":"10","author":"\u00c7 Y\u00fccel","year":"2023","unstructured":"Y\u00fccel \u00c7, Serto\u011flu E, Omma A, Ko\u00e7ak E, Erdo\u011fan Kablan S, \u00d6zg\u00fcrta\u015f T, Nemutlu E. Comparative Metabolomic Profiles of Vascular Involvement in Beh\u00e7et\u2019s Disease. Eur J Rheumatol. 2023;10(4):130\u20135. https:\/\/doi.org\/10.5152\/eurjrheum.2023.23062 . PMID: 37850605; PMCID: PMC10765176.","journal-title":"Eur J Rheumatol"},{"key":"4944_CR14","doi-asserted-by":"publisher","unstructured":"Ma R, Zhu Y, Li X, Hu S, Zheng D, Xiong S, Xu S, Xiang L, Zhao M, Tang C, Zeng Z, Chen M, Feng R. A Novel Serum Metabolomic Panel for the Diagnosis of Crohn\u2019s Disease. Inflamm Bowel Dis. 2023;29(10):1524\u201335. https:\/\/doi.org\/10.1093\/ibd\/izad080. PMID: 37195904.","DOI":"10.1093\/ibd\/izad080"},{"issue":"10","key":"4944_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11306-018-1439-4","volume":"14","author":"A Murgia","year":"2018","unstructured":"Murgia A, Hinz C, Liggi S, et al. Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels. Metabolomics. 2018;14(10):140. https:\/\/doi.org\/10.1007\/s11306-018-1439-4. Published 2018 Oct 10.","journal-title":"Metabolomics"},{"issue":"11","key":"4944_CR16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","volume":"73","author":"A Vich Vila","year":"2024","unstructured":"Vich Vila A, Zhang J, Liu M, Faber KN, Weersma RK. Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases. Gut. 2024;73(11):1909\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2023-329969. Published 2024 Oct 7.","journal-title":"Gut"},{"issue":"1","key":"4944_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","volume":"14","author":"H Julkunen","year":"2023","unstructured":"Julkunen H, Cicho\u0144ska A, Tiainen M, et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023;14(1):604. https:\/\/doi.org\/10.1038\/s41467-023-36231-7. Published 2023 Feb 3.","journal-title":"Nat Commun"},{"issue":"1","key":"4944_CR18","doi-asserted-by":"publisher","first-page":"2527863","DOI":"10.1080\/19490976.2025.2527863","volume":"17","author":"ST Radhakrishnan","year":"2025","unstructured":"Radhakrishnan ST, Mullish BH, Olbei ML, et al. Deciphering the microbiome- metabolome landscape of an inflammatory bowel disease inception cohort. Gut Microbes. 2025;17(1):2527863. https:\/\/doi.org\/10.1080\/19490976.2025.2527863.","journal-title":"Gut Microbes"},{"key":"4944_CR19","doi-asserted-by":"publisher","first-page":"105056","DOI":"10.1016\/j.ebiom.2024.105056","volume":"102","author":"DMM Harris","year":"2024","unstructured":"Harris DMM, Szymczak S, Schuchardt S, et al. Tryptophan degradation as a systems phenomenon in inflammation - an analysis across 13 chronic inflammatory diseases. EBioMedicine. 2024;102:105056. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105056.","journal-title":"EBioMedicine"},{"issue":"1","key":"4944_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mri.2008.05.014","volume":"27","author":"K Balasubramanian","year":"2009","unstructured":"Balasubramanian K, Kumar S, Singh RR, Sharma U, Ahuja V, Makharia GK, Jagannathan NR. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging. 2009;27(1):79\u201386. https:\/\/doi.org\/10.1016\/j.mri.2008.05.014. Epub 2008 Jul\u00a03. PMID: 1859924.","journal-title":"Magn Reson Imaging"},{"key":"4944_CR21","doi-asserted-by":"publisher","unstructured":"Santoru ML, Piras C, Murgia F, Leoni VP, Spada M, Murgia A, Liggi S, Lai MA, Usai P, Caboni P, Manzin A, Atzori L. Metabolic Alteration in Plasma and Biopsies From Patients With IBD. Inflamm Bowel Dis. 2021;27(8):1335\u201345. https:\/\/doi.org\/10.1093\/ibd\/izab012. PMID: 33512485.","DOI":"10.1093\/ibd\/izab012"},{"issue":"3","key":"4944_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/metabo13030451","volume":"13","author":"F Qin","year":"2023","unstructured":"Qin F, Li J, Mao T, Feng S, Li J, Lai M. 2 Hydroxybutyric Acid-Producing Bacteria in Gut Microbiome and Fusobacterium nucleatum Regulates 2 Hydroxybutyric Acid Level. Vivo Metabolites. 2023;13(3):451. https:\/\/doi.org\/10.3390\/metabo13030451 . PMID: 36984891; PMCID: PMC10059959.","journal-title":"Vivo Metabolites"},{"key":"4944_CR23","doi-asserted-by":"publisher","first-page":"606298","DOI":"10.3389\/fmed.2020.606298","volume":"7","author":"J Sankarasubramanian","year":"2020","unstructured":"Sankarasubramanian J, Ahmad R, Avuthu N, Singh AB, Guda C. Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn\u2019s Disease. Front Med (Lausanne). 2020;7:606298. https:\/\/doi.org\/10.3389\/fmed.2020.606298 . PMID: 33330572; PMCID: PMC7729129.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4944_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jgh.16043","volume":"38","author":"KG Upadhyay","year":"2023","unstructured":"Upadhyay KG, Desai DC, Ashavaid TF, Dherai AJ. Microbiome and metabolome in inflammatory bowel disease. J Gastroenterol Hepatol. 2023;38(1):34\u201343. https:\/\/doi.org\/10.1111\/jgh.16043 . Epub 2022 Nov 6. PMID: 36287112.","journal-title":"J Gastroenterol Hepatol"},{"key":"4944_CR25","doi-asserted-by":"publisher","unstructured":"Shores DR, Binion DG, Freeman BA, Baker PR. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(10):2192\u2013204. https:\/\/doi.org\/10.1002\/ibd.21560. Epub 2010 Dec 3. PMID: 21910181; PMCID: PMC4100336.","DOI":"10.1002\/ibd.21560"},{"issue":"1","key":"4944_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","volume":"8","author":"ZN Ling","year":"2023","unstructured":"Ling ZN, Jiang YF, Ru JN, Lu JH, Ding B, Wu J. Amino acid metabolism in health and disease. Signal Transduct Target Ther. 2023;8(1):345. https:\/\/doi.org\/10.1038\/s41392-023-01569-3 . PMID: 37699892; PMCID: PMC10497558.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4944_CR27","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00726-017-2493-3","volume":"49","author":"R Lin","year":"2017","unstructured":"Lin R, Liu W, Piao M, Zhu H. A review of the relationship between the gut microbiota and amino acid metabolism. Amino Acids. 2017;49(12):2083\u201390. https:\/\/doi.org\/10.1007\/s00726-017-2493-3 . Epub 2017 Sep 20. PMID: 28932911.","journal-title":"Amino Acids"},{"key":"4944_CR28","doi-asserted-by":"publisher","first-page":"1190607","DOI":"10.3389\/fimmu.2023.1190607","volume":"14","author":"Q Lei","year":"2023","unstructured":"Lei Q, Yang J, Li L, et al. Lipid metabolism and rheumatoid arthritis. Front Immunol. 2023;14:1190607. https:\/\/doi.org\/10.3389\/fimmu.2023.1190607. Published 2023 May 31.","journal-title":"Front Immunol"},{"key":"4944_CR29","doi-asserted-by":"publisher","first-page":"571237","DOI":"10.3389\/fcell.2020.571237","volume":"8","author":"G Preta","year":"2020","unstructured":"Preta G. New Insights Into Targeting Membrane Lipids for Cancer Therapy. Front Cell Dev Biol. 2020;8:571237. https:\/\/doi.org\/10.3389\/fcell.2020.571237. Published 2020 Sep 2.","journal-title":"Front Cell Dev Biol"},{"key":"4944_CR30","doi-asserted-by":"publisher","first-page":"768606","DOI":"10.3389\/fimmu.2022.768606","volume":"13","author":"RF Saito","year":"2022","unstructured":"Saito RF, Andrade LNS, Bustos SO, Chammas R. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells. Front Immunol. 2022;13:768606. https:\/\/doi.org\/10.3389\/fimmu.2022.768606. Published 2022 Feb 15.","journal-title":"Front Immunol"},{"issue":"7","key":"4944_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/MIB.0000000000000394","volume":"21","author":"F Fan","year":"2015","unstructured":"Fan F, Mundra PA, Fang L, et al. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn\u2019s Disease. Inflamm Bowel Dis. 2015;21(7):1511\u20138. https:\/\/doi.org\/10.1097\/MIB.0000000000000394.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"4944_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acs.jproteome.9b00440","volume":"19","author":"S Guan","year":"2020","unstructured":"Guan S, Jia B, Chao K, et al. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. J Proteome Res. 2020;19(2):600\u20139. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00440.","journal-title":"J Proteome Res"},{"issue":"30","key":"4944_CR33","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.2174\/092986707782793899","volume":"14","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem. 2007;14(30):3209\u201320. https:\/\/doi.org\/10.2174\/092986707782793899.","journal-title":"Curr Med Chem"},{"issue":"4","key":"4944_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/advances\/nmaa024","volume":"11","author":"RD Semba","year":"2020","unstructured":"Semba RD, Perspective. The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease. Adv Nutr. 2020;11(4):760\u201372. https:\/\/doi.org\/10.1093\/advances\/nmaa024.","journal-title":"Adv Nutr"},{"issue":"8","key":"4944_CR35","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/jgh.15067","volume":"35","author":"S Iwatani","year":"2020","unstructured":"Iwatani S, Iijima H, Otake Y, et al. Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2020;35(8):1355\u201364. https:\/\/doi.org\/10.1111\/jgh.15067.","journal-title":"J Gastroenterol Hepatol"},{"key":"4944_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","volume":"321","author":"E Calzada","year":"2016","unstructured":"Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016;321:29\u201388. https:\/\/doi.org\/10.1016\/bs.ircmb.2015.10.001.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"4944_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","volume":"3","author":"Z Li","year":"2006","unstructured":"Li Z, Agellon LB, Allen TM, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006;3(5):321\u201331. https:\/\/doi.org\/10.1016\/j.cmet.2006.03.007.","journal-title":"Cell Metab"},{"key":"4944_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2017.02.035","volume":"111","author":"V Serbulea","year":"2017","unstructured":"Serbulea V, DeWeese D, Leitinger N. The effect of oxidized phospholipids on phenotypic polarization and function of macrophages. Free Radic Biol Med. 2017;111:156\u201368. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.02.035.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"4944_CR39","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ibd\/izac281","volume":"29","author":"R Ferru-Cl\u00e9ment","year":"2023","unstructured":"Ferru-Cl\u00e9ment R, Boucher G, Forest A, et al. Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn\u2019s Disease. Inflamm Bowel Dis. 2023;29(7):1024\u201337. https:\/\/doi.org\/10.1093\/ibd\/izac281.","journal-title":"Inflamm Bowel Dis"},{"key":"4944_CR40","doi-asserted-by":"publisher","unstructured":"Hanamatsu H, Ohnishi S, Sakai S, et al. Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. Nutr Diabetes. 2014;4(10):e141. https:\/\/doi.org\/10.1038\/nutd.2014.38.","DOI":"10.1038\/nutd.2014.38"},{"issue":"1","key":"4944_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00041433-200302000-00006","volume":"14","author":"N Tada","year":"2003","unstructured":"Tada N, Yoshida H. Diacylglycerol on lipid metabolism. Curr Opin Lipidol. 2003;14(1):29\u201333. https:\/\/doi.org\/10.1097\/00041433-200302000-00006.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"4944_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1189\/jlb.1111537","volume":"92","author":"KR Feingold","year":"2012","unstructured":"Feingold KR, Shigenaga JK, Kazemi MR, et al. Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol. 2012;92(4):829\u201339. https:\/\/doi.org\/10.1189\/jlb.1111537.","journal-title":"J Leukoc Biol"},{"key":"4944_CR43","doi-asserted-by":"publisher","first-page":"108808","DOI":"10.1016\/j.jnutbio.2021.108808","volume":"97","author":"SC Di Rienzi","year":"2021","unstructured":"Di Rienzi SC, Johnson EL, Waters JL, et al. The microbiome affects liver sphingolipids and plasma fatty acids in a murine model of the Western diet based on soybean oil. J Nutr Biochem. 2021;97:108808. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108808.","journal-title":"J Nutr Biochem"},{"key":"4944_CR44","doi-asserted-by":"publisher","unstructured":"Gaifem J, Gon\u00e7alves LG, Dinis-Oliveira RJ, et al. L-Threonine Supplementation During Colitis Onset Delays Disease Recovery. Front Physiol. 2018;9:1247. https:\/\/doi.org\/10.3389\/fphys.2018.01247.","DOI":"10.3389\/fphys.2018.01247"},{"key":"4944_CR45","doi-asserted-by":"publisher","unstructured":"Jeong SY, Im YN, Youm JY, Lee HK, Im SY. l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1. Nutrients. 2018;10(3):288. https:\/\/doi.org\/10.3390\/nu10030288.","DOI":"10.3390\/nu10030288"},{"key":"4944_CR46","doi-asserted-by":"publisher","first-page":"1284133","DOI":"10.3389\/fimmu.2023.1284133","volume":"14","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhu Y, Zhao Z, Chu Y, Yang W. The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases. Front Immunol. 2023;14:1284133. https:\/\/doi.org\/10.3389\/fimmu.2023.1284133. Published 2023 Oct 23.","journal-title":"Front Immunol"},{"issue":"9","key":"4944_CR47","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79. https:\/\/doi.org\/10.1186\/gb-2012-13-9-r79. Published 2012 Apr 16.","journal-title":"Genome Biol"},{"issue":"2","key":"4944_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/gutjnl-2022-329297","volume":"73","author":"JL Alexander","year":"2024","unstructured":"Alexander JL, Wyatt NJ, Camuzeaux S, et al. Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research. Gut. 2024;73(2):379\u201383. https:\/\/doi.org\/10.1136\/gutjnl-2022-329297. Published 2024 Jan 5.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04944-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:16:20Z","timestamp":1784074580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04944-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4944"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04944-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Gazi University Faculty of Medicine Hospital (Approval Date: March 6, 2023; Decision Number: 200). The study was conducted in accordance with the principles of the Declaration of Helsinki.Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Nurulamin M. Noor has received educational grants and\/or speaker fees from AbbVie, BMS, Celltrion, Dr Falk, Ferring, Johnson & Johnson, Lilly, Medfyle, Pfizer, Pharmacosmos, Takeda, and Tillotts. Dr. Stephan L. Haas has served as a speaker and\/or advisory board member for Celltrion, Ferring, Janssen, Lilly, Mediahuset, Pfizer, Santax Medico, Takeda, and Tillotts Pharma. All other authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"449"}}